多西他赛联合吡柔比星在晚期乳腺癌的护理干效果分析
潘道霞;杨惠文
【期刊名称】《中国生化药物杂志》 【年(卷),期】2017(037)008
【摘要】Objective To investigate the nursing intervention and efficacy of docetaxel combined with pirarubicin in the treatment of advanced breast cancer. Methods In our hospital from January 2014 to February 2015 were selected from the patients with advanced breast cancer in 94 cases as the research object, the single and double number (hospital admission order) of the selected patients with advanced breast cancer were randomly divided into study group and control group, 41 cases in each group. 2 groups of patients with advanced breast cancer were treated with docetaxel combined with pirarubicin, the control group was given routine nursing services, and the study group was given comprehensive nursing intervention measures on the basis of routine care. Results Of the 2 groups of patients with advanced breast cancer nursing after different nursing measures the same drug plan, after the study group, the total efficiency of treatment in the method [please explain what is \than the control group (61.70%), the difference was statistically significant (P<0.05); the study group the nursing service satisfaction was significantly better than the control group (P<0.05). Conclusion With
the combination of docetaxel and pirarubicin in the treatment of advanced breast cancer patients, comprehensive nursing measures can achieve better clinical efficacy and benefit the maintenance of good relationship between nurses and patients.%目的 探讨晚期乳腺癌患者接受多西他赛联合吡柔比星治疗过程中的护理干预方法及效果.方法 本文将选取本院2014年1月~2015年2月期间收治的晚期乳腺癌患者94例作为本次研究对象,经单双数字法(入院就诊顺序)将本次入选的晚期乳腺癌患者随机均分为研究组和对照组,每组各47例.2组晚期乳腺癌患者均接受多西他赛联合吡柔比星治疗,予以对照组常规护理服务,研究组在常规护理基础上加用综合性护理干预措施.结果 2组晚期乳腺癌患者经相同药物方案、不同护理措施护理后,研究组近期治疗总有效率(82.98%)显著优于对照组(61.70%),差异有统计学意义(P<0.05);研究组对本次护理服务满意度显著优于对照组(P<0.05).结论 应用多西他赛、吡柔比星治疗晚期乳腺癌患者时,综合性护理措施可使获得更理想的临床疗效,有利于维持良好的护患关系. 【总页数】3页(95-96,99)
【关键词】多西他赛;吡柔比星;乳腺癌;护理干预 【作者】潘道霞;杨惠文
【作者单位】浙江中医药大学附属第二医院(新华医院) 肿瘤外科,浙江 杭州 310053;浙江中医药大学附属第二医院(新华医院) 肿瘤外科,浙江 杭州 310053 【正文语种】中文 【中图分类】R737.9 【文献来源】
https://www.zhangqiaokeyan.com/academic-journal-cn_chinese-journal-biochemical-pharmaceuticals_thesis/0201242949057.html 【相关文献】
1.吡柔比星联合多西他赛与环磷酰胺治疗晚期乳腺癌效果分析 [J], 马松良; 唐长菱
2.多西他赛联合吡柔比星与顺铂2种方案治疗晚期乳腺癌的临床疗效观察 [J], 刘驯炎; 谢林浩; 李蔚冰
3.多西他赛联合吡柔比星在晚期乳腺癌新辅助化疗中的临床疗效观察 [J], 李鲲鹏; 朱宏辉
4.吡柔比星和环磷酰胺联合多西他赛在乳腺癌新辅助化疗中应用效果 [J], 阙劲松
5.多西他赛、环磷酰胺与多西他赛、吡柔比星新辅助化疗方案治疗局部晚期乳腺癌疗效分析 [J], 郭峰; 刘辉; 张成雷; 任立军; 孙清慧
以上内容为文献基本信息，获取文献全文请下载
多西他赛联合吡柔比星在晚期乳腺癌的护理干效果分析
